Addition of adjuvant progesterone to physical‐exam‐indicated cervical cerclage to prevent preterm birth

The aim of this study was to assess the effect of vaginal progesterone as an adjuvant therapy to physical‐exam‐indicated cervical cerclage (PEICC).

[1]  A. Ragab,et al.  To do or not to do emergency cervical cerclage (a rescue stitch) at 24–28 weeks gestation in addition to progesterone for patients coming early in labor? A prospective randomized trial for efficacy and safety , 2015, Archives of Gynecology and Obstetrics.

[2]  R. Porcher,et al.  17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial. , 2015, American journal of obstetrics and gynecology.

[3]  Eman S. Alsulmi,et al.  Cervical insufficiency and cervical cerclage. , 2014, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[4]  H. Al-Inany,et al.  A review of the contemporary evidence on rescue cervical cerclage , 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[5]  R. Gagnon,et al.  Cervical insufficiency and cervical cerclage. , 2013, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[6]  R. Romero,et al.  Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice. , 2013, American journal of obstetrics and gynecology.

[7]  L. Muglia,et al.  Adjunctive Therapies to Cerclage for the Prevention of Preterm Birth: A Systematic Review , 2013, Obstetrics and gynecology international.

[8]  A. Abdelaziz,et al.  Prevention of preterm birth: a randomized trial of vaginal compared with intramuscular progesterone , 2013, Acta obstetricia et gynecologica Scandinavica.

[9]  V. Berghella,et al.  Effectiveness of 17-α-Hydroxyprogesterone Caproate on Preterm Birth Prevention in Women with History-Indicated Cerclage , 2013, American Journal of Perinatology.

[10]  G. Saade,et al.  17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. , 2012, American journal of obstetrics and gynecology.

[11]  Gynecologists.  Practice bulletin no. 130: prediction and prevention of preterm birth. , 2012, Obstetrics and gynecology.

[12]  D. Wing,et al.  Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[13]  K. Park,et al.  Noninvasive Prediction of Intra-Amniotic Infection and/or Inflammation in Preterm Premature Rupture of Membranes , 2012, Reproductive Sciences.

[14]  L. Sullivan,et al.  Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double‐blind, placebo‐controlled trial , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[15]  Vincenzo Berghella1,et al.  The Effect of 17α-Hydroxyprogesterone Caproate on Preterm Birth in Women with an Ultrasound-Indicated Cerclage , 2011, American journal of perinatology.

[16]  B. Yoon,et al.  Detection of ureaplasmas by the polymerase chain reaction in the amniotic fluid of patients with cervical insufficiency , 2010, Journal of perinatal medicine.

[17]  D. Wing,et al.  17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length. , 2009, American journal of obstetrics and gynecology.

[18]  G. Ventolini,et al.  Pregnancy outcome after placement of ‘rescue’ Shirodkar cerclage , 2009, Journal of Perinatology.

[19]  R. Romero,et al.  The Frequency and Significance of Intraamniotic Inflammation in Patients With Cervical Insufficiency , 2008 .

[20]  J. Dudenhausen,et al.  Emergency cerclage versus bed rest for amniotic sac prolapse before 27 gestational weeks. A retrospective, comparative study of 161 women. , 2008, European journal of obstetrics, gynecology, and reproductive biology.

[21]  A. Rebarber,et al.  The use of 17 alpha-hydroxyprogesterone caproate (17p) in women with cervical cerclage. , 2008, American journal of perinatology.

[22]  S. Daly,et al.  Expectant management compared with physical examination-indicated cerclage (EM-PEC) in selected women with a dilated cervix at 14(0/7)-25(6/7) weeks: results from the EM-PEC international cohort study. , 2007, American journal of obstetrics and gynecology.

[23]  J. Weeks,et al.  Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double‐blind, placebo‐controlled trial , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[24]  K. Nicolaides,et al.  Progesterone and the risk of preterm birth among women with a short cervix. , 2007, The New England journal of medicine.

[25]  P. Williamson,et al.  Cervical cerclage for prevention of preterm delivery in women with short cervix , 2004, The Lancet.

[26]  H. V. van Geijn,et al.  Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone. , 2003, American journal of obstetrics and gynecology.

[27]  R. P. Heine,et al.  Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. , 2003, The New England journal of medicine.

[28]  M. Zugaib,et al.  Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. , 2003, American journal of obstetrics and gynecology.

[29]  H. V. van Geijn,et al.  Cervical incompetence prevention randomized cerclage trial (CIPRACT): study design and preliminary results. , 2000, American journal of obstetrics and gynecology.

[30]  A. Calder,et al.  The Effects of Mifepristone on Cervical Ripening and Labor Induction in Primigravidae , 1998, Obstetrics and gynecology.

[31]  Ø. Lidegaard.  Cervical incompetence and cerclage in Denmark 198O‐1990 A register based epidemiological survey , 1994, Acta obstetricia et gynecologica Scandinavica.

[32]  R. Frydman,et al.  Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses. , 1988, Human reproduction.

[33]  Kate C. Arnold,et al.  Cerclage for the Management of Cervical Insufficiency , 2017 .